Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.24, Iss.5, 2014-09, pp. : 1102-1114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Biological marker no surrogate for response in accelerated approval
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Approval of bevacizumab (Avastin) for use in metastatic breast cancer (mBC) has been suspended
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :